{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T20:13:09Z","timestamp":1782504789856,"version":"3.54.5"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"DOI":"10.1007\/s11239-025-03224-w","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T16:12:44Z","timestamp":1767024764000},"page":"1044-1049","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Implementing anticoagulation stewardship: the use of a dedicated mobile phone \u2018app\u2019 in the experience of the Italian Federation of Anticoagulation linics (FCSA)"],"prefix":"10.1007","volume":"59","author":[{"given":"Daniela","family":"Poli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Bucciarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Cappugi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco Paolo","family":"Donadini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Pengo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Rescigno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Sarti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Testa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Toschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Squizzato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,29]]},"reference":[{"key":"3224_CR1","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1093\/intqhc\/mzy177","volume":"31","author":"AR Dreijer","year":"2019","unstructured":"Dreijer AR, Diepstraten J, Bukkems VE, Mol PGM, Leebeek FWG, Kruip M, van den Bemt P (2019) Anticoagulant medication errors in hospitals and primary care: a cross-sectional study. Int J Qual Health Care 31:346\u2013352","journal-title":"Int J Qual Health Care"},{"key":"3224_CR2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0044-1782688","author":"S Galliazzo","year":"2024","unstructured":"Galliazzo S, Bucciarelli P et al (2024) Practical suggestions for an optimal management of vitamin K antagonists: Italian Federation of Centers for the Diagnosis of Thrombotic Disorders and the Surveillance of the Antithrombotic Therapies (FCSA) position paper. Thromb Haemost. https:\/\/doi.org\/10.1055\/s-0044-1782688","journal-title":"Thromb Haemost"},{"key":"3224_CR3","first-page":"244","volume":"15","author":"WL Baker","year":"2009","unstructured":"Baker WL, Cios DA, Sander SD, Coleman CI (2009) Meta-analysis to assess the quality of warfarin control in atrial fibrillation patients in the United States. J Manag Care Pharm 15:244\u2013252","journal-title":"J Manag Care Pharm"},{"key":"3224_CR4","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.thromres.2018.01.024","volume":"163","author":"E Phelps","year":"2018","unstructured":"Phelps E, Delate T, Witt DM, Shaw PB, McCool KH, Clark NP (2018) Effect of increased time in the therapeutic range on atrial fibrillation outcomes within a centralized anticoagulation service. Thromb Res 163:54\u201359","journal-title":"Thromb Res"},{"key":"3224_CR5","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1182\/bloodadvances.2023012408","volume":"8","author":"S Testa","year":"2024","unstructured":"Testa S, Palareti G et al (2024) Thrombotic events associated with low baseline direct oral anticoagulant levels in atrial fibrillation: the MAS study. Blood Adv 8:1846\u20131856","journal-title":"Blood Adv"},{"key":"3224_CR6","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2024013126","author":"G Palareti","year":"2024","unstructured":"Palareti G, Testa S et al (2024) More early bleeds associated with high baseline direct oral anticoagulant levels in atrial fibrillation: the Mas study. Blood Adv. https:\/\/doi.org\/10.1182\/bloodadvances.2024013126","journal-title":"Blood Adv"},{"key":"3224_CR7","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1016\/j.jacc.2020.07.045","volume":"76","author":"AJ Camm","year":"2020","unstructured":"Camm AJ, Cools F, Virdone S et al (2020) Mortality in patients with atrial fibrillation receiving nonrecommended doses of direct oral anticoagulants. J Am Coll Cardiol 76:1425\u20131436","journal-title":"J Am Coll Cardiol"},{"key":"3224_CR8","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1136\/heartjnl-2022-321114","volume":"109","author":"V Caso","year":"2023","unstructured":"Caso V, de Groot JR et al (2023) Outcomes and drivers of inappropriate dosing of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a systematic review and meta-analysis. Heart 109:178\u2013185","journal-title":"Heart"},{"key":"3224_CR9","doi-asserted-by":"crossref","unstructured":"Poli D, Antonucci E, Ageno W, Berteotti M, Falanga A, Pengo V, Chiarugi P, Cosmi B, Paparo C, Chistolini A, Insana A, Lione D, Malcangi G, Martini G, Masciocco L, Pedrini S, Bucherini E, Pastori D, Pignatelli P, Toma A, Testa S, Palareti G and Start Af Study G (2024) Inappropriate underdosing of direct oral anticoagulants in atrial fibrillation patients: results from the START2-AF registry. J clin med.13.","DOI":"10.3390\/jcm13072009"},{"key":"3224_CR10","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1016\/j.jacc.2016.09.966","volume":"68","author":"BA Steinberg","year":"2016","unstructured":"Steinberg BA, Shrader P et al (2016) Off-label dosing of non-vitamin K antagonist oral anticoagulants and adverse outcomes: the ORBIT-AF II registry. J Am Coll Cardiol 68:2597\u20132604 (Investigators O-A and Patients)","journal-title":"J Am Coll Cardiol"},{"key":"3224_CR11","doi-asserted-by":"publisher","DOI":"10.1378\/chest.11-2404","volume":"141","author":"Y Falck-Ytter","year":"2012","unstructured":"Falck-Ytter Y, Francis CW, Johanson NA, Curley C, Dahl OE, Schulman S, Ortel TL, Pauker SG, Colwell CW Jr. (2012) Prevention of VTE in orthopedic surgery patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 141:e278S-e325S","journal-title":"Chest"},{"key":"3224_CR12","doi-asserted-by":"publisher","first-page":"e227S","DOI":"10.1378\/chest.11-2297","volume":"141","author":"MK Gould","year":"2012","unstructured":"Gould MK, Garcia DA, Wren SM, Karanicolas PJ, Arcelus JI, Heit JA, Samama CM (2012) Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 141:e227S-e277S","journal-title":"Chest"},{"key":"3224_CR13","doi-asserted-by":"publisher","first-page":"3198","DOI":"10.1182\/bloodadvances.2018022954","volume":"2","author":"HJ Schunemann","year":"2018","unstructured":"Schunemann HJ, Cushman M et al (2018) American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients. Blood Adv 2:3198\u20133225","journal-title":"Blood Adv"},{"key":"3224_CR14","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s11239-015-1189-3","volume":"40","author":"DP Reardon","year":"2015","unstructured":"Reardon DP, Atay JK, Ashley SW, Churchill WW, Berliner N, Connors JM (2015) Implementation of a hemostatic and antithrombotic stewardship program. J Thromb Thrombolysis 40:379\u2013382","journal-title":"J Thromb Thrombolysis"},{"key":"3224_CR15","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1007\/s11239-016-1408-6","volume":"42","author":"BM Ritchie","year":"2016","unstructured":"Ritchie BM, Sylvester KW, Reardon DP, Churchill WW, Berliner N, Connors JM (2016) Treatment of heparin-induced thrombocytopenia before and after the implementation of a hemostatic and antithrombotic stewardship program. J Thromb Thrombolysis 42:616\u2013622","journal-title":"J Thromb Thrombolysis"},{"key":"3224_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0235048","volume":"15","author":"AR Dreijer","year":"2020","unstructured":"Dreijer AR, Kruip M, Diepstraten J, Polinder S, Brouwer R, Mol PGM, Croles FN, Kragten E, Leebeek FWG, van den Bemt P (2020) Effect of antithrombotic stewardship on the efficacy and safety of antithrombotic therapy during and after hospitalization. PLoS One 15:e0235048","journal-title":"PLoS One"},{"key":"3224_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/rth2.12757","volume":"6","author":"AE Burnett","year":"2022","unstructured":"Burnett AE, Barnes GD (2022) A call to action for anticoagulation stewardship. Res Pract Thromb Haemost 6:e12757","journal-title":"Res Pract Thromb Haemost"},{"key":"3224_CR18","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1007\/s11239-016-1455-z","volume":"43","author":"MK Wychowski","year":"2017","unstructured":"Wychowski MK, Ruscio CI, Kouides PA, Sham RL (2017) The scope and value of an anticoagulation stewardship program at a community teaching hospital. J Thromb Thrombolysis 43:380\u2013386","journal-title":"J Thromb Thrombolysis"},{"key":"3224_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/rth2.12758","volume":"6","author":"M Koolian","year":"2022","unstructured":"Koolian M, Wiseman D, Mantzanis H, Kampouris N, Kerzner RS, Kahn SR (2022) Anticoagulation stewardship: descriptive analysis of a novel approach to appropriate anticoagulant prescription. Res Pract Thromb Haemost 6:e12758","journal-title":"Res Pract Thromb Haemost"},{"key":"3224_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2024.05.009","volume":"239","author":"T Wan","year":"2024","unstructured":"Wan T, Garland SJ, Drury CT, Lambert J, Yoon J, Chan M (2024) Anticoagulation stewardship: improving adherence to clinical guidelines and reducing overuse of venous thromboembolism prophylaxis in hospitalized medical patients. Thromb Res 239:109036","journal-title":"Thromb Res"},{"key":"3224_CR21","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.124.035859","volume":"13","author":"GD Barnes","year":"2024","unstructured":"Barnes GD, Chen C, Holleman R, Errickson J, Seagull FJ, Dorsch MP, Allen AL, Spoutz P, Sussman JB (2024) Pharmacist use of a population management dashboard for safe anticoagulant prescribing: evaluation of a nationwide implementation effort. J Am Heart Assoc 13:e035859","journal-title":"J Am Heart Assoc"},{"key":"3224_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0144314","volume":"10","author":"A Tosetto","year":"2015","unstructured":"Tosetto A, Manotti C, Marongiu F, Italian Federation of Anticoagulation Clinics clinical quality study g (2015) Center-related determinants of VKA anticoagulation quality: a prospective, multicenter evaluation. PLoS One 10:e0144314","journal-title":"PLoS One"},{"key":"3224_CR23","first-page":"196","volume":"11","author":"D Prisco","year":"1996","unstructured":"Prisco D (1996) Poli D and Palareti G [Therapeutic ranges of oral anticoagulant therapy in different diseases. Guidelines of the Federation of Centers of Surveillance of Patients on Anticoagulation. Ad hoc Study Group]. Ann Ital Med Int 11:196\u2013203","journal-title":"Ann Ital Med Int"},{"key":"3224_CR24","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1055\/a-1715-5960","volume":"122","author":"A Squizzato","year":"2022","unstructured":"Squizzato A, Poli D, Barcellona D, Ciampa A, Grandone E, Manotti C, Moia M, Toschi V, Tosetto A, Testa S, Scientific Reviewer C (2022) Management of DOAC in patients undergoing planned surgery or invasive procedure: Italian Federation of Centers for the Diagnosis of Thrombotic Disorders and the Surveillance of the Antithrombotic Therapies (FCSA) position paper. Thromb Haemost 122:329\u2013335","journal-title":"Thromb Haemost"},{"key":"3224_CR25","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s11739-020-02391-3","volume":"15","author":"D Poli","year":"2020","unstructured":"Poli D, Tosetto A, Palareti G, Barcellona D, Ciampa A, Grandone E, Manotti C, Moia M, Squizzato A, Toschi V, Testa S, On the behalf of Italian Federation of Anticoagulation C (2020) Managing anticoagulation in the COVID-19 era between lockdown and reopening phases. Intern Emerg Med 15:783\u2013786","journal-title":"Intern Emerg Med"},{"key":"3224_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.rpth.2023.100137","volume":"7","author":"M Candeloro","year":"2023","unstructured":"Candeloro M, Carlin S, Shapiro MJ, Douketis JD (2023) Drug-drug interactions between direct oral anticoagulants and anticonvulsants and clinical outcomes: a systematic review. Res Pract Thromb Haemost 7:100137","journal-title":"Res Pract Thromb Haemost"},{"key":"3224_CR27","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.3389\/fneur.2018.01067","volume":"9","author":"A Galgani","year":"2018","unstructured":"Galgani A, Palleria C, Iannone LF, De Sarro G, Giorgi FS, Maschio M, Russo E (2018) Pharmacokinetic interactions of clinical interest between direct oral anticoagulants and antiepileptic drugs. Front Neurol 9:1067","journal-title":"Front Neurol"},{"key":"3224_CR28","first-page":"462","volume":"16","author":"A Tripodi","year":"2018","unstructured":"Tripodi A, Ageno W et al (2018) Position paper on laboratory testing for patients on direct oral anticoagulants. A consensus document from the SISET, FCSA, SIBioC and SIPMeL. Blood transfusion = Trasfusione del sangue 16:462\u2013470","journal-title":"Blood transfusion = Trasfusione del sangue"},{"key":"3224_CR29","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1182\/blood-2018-04-848333","volume":"132","author":"V Pengo","year":"2018","unstructured":"Pengo V, Denas G et al (2018) Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome. Blood 132:1365\u20131371","journal-title":"Blood"},{"key":"3224_CR30","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jacc.2022.10.008","volume":"81","author":"CD Khairani","year":"2023","unstructured":"Khairani CD, Bejjani A et al (2023) Direct oral anticoagulants vs vitamin K antagonists in patients with antiphospholipid syndromes: meta-analysis of randomized trials. J Am Coll Cardiol 81:16\u201330","journal-title":"J Am Coll Cardiol"},{"key":"3224_CR31","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1002\/art.42624","volume":"75","author":"M Barbhaiya","year":"2023","unstructured":"Barbhaiya M, Zuily S, Naden R et al (2023) The 2023 ACR\/EULAR antiphospholipid syndrome classification criteria. Arthritis Rheum 75:1687\u20131702","journal-title":"Arthritis Rheum"},{"key":"3224_CR32","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1182\/blood-2015-08-665927","volume":"127","author":"I Martinelli","year":"2016","unstructured":"Martinelli I, Lensing AW et al (2016) Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy use. Blood 127:1417\u20131425","journal-title":"Blood"},{"key":"3224_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.rpth.2023.100072","volume":"7","author":"JP Patel","year":"2023","unstructured":"Patel JP, Nzelu O, Roberts LN, Johns J, Ross J, Arya R (2023) How do anticoagulants impact menstrual bleeding and quality of life? - The PERIOD study. Res Pract Thromb Haemost 7:100072","journal-title":"Res Pract Thromb Haemost"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-025-03224-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-025-03224-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-025-03224-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T08:32:38Z","timestamp":1781339558000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-025-03224-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,29]]},"references-count":33,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["3224"],"URL":"https:\/\/doi.org\/10.1007\/s11239-025-03224-w","relation":{},"ISSN":["1573-742X"],"issn-type":[{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,29]]},"assertion":[{"value":"13 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}